Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 24,000 shares of Simulations Plus stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $31.71, for a total value of $761,040.00. Following the sale, the director now directly owns 4,874,772 shares in the company, valued at approximately $154,579,020.12. The sale was disclosed in a document filed with the SEC, which is available at this link.
Shares of NASDAQ:SLP opened at $33.07 on Friday. Simulations Plus, Inc. has a 1-year low of $19.74 and a 1-year high of $41.95. The firm has a market capitalization of $583.45 million, a PE ratio of 66.14 and a beta of -0.38. The business’s 50 day moving average is $33.78 and its 200-day moving average is $33.78. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.01.
Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Thursday, January 9th. The technology company reported $0.11 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.10 by $0.01. The business had revenue of $9.40 million for the quarter, compared to analyst estimates of $8.37 million. Simulations Plus had a return on equity of 24.84% and a net margin of 25.41%. On average, sell-side analysts predict that Simulations Plus, Inc. will post 0.54 EPS for the current year.
A number of hedge funds have recently made changes to their positions in the stock. William Blair Investment Management LLC boosted its stake in Simulations Plus by 29.5% in the 4th quarter. William Blair Investment Management LLC now owns 498,566 shares of the technology company’s stock valued at $14,493,000 after buying an additional 113,483 shares in the last quarter. Royce & Associates LP boosted its stake in Simulations Plus by 39.1% in the 4th quarter. Royce & Associates LP now owns 429,070 shares of the technology company’s stock valued at $12,473,000 after buying an additional 120,514 shares in the last quarter. State Street Corp boosted its stake in Simulations Plus by 5.8% in the 4th quarter. State Street Corp now owns 263,231 shares of the technology company’s stock valued at $7,652,000 after buying an additional 14,407 shares in the last quarter. Russell Investments Group Ltd. boosted its stake in Simulations Plus by 29.4% in the 4th quarter. Russell Investments Group Ltd. now owns 236,682 shares of the technology company’s stock valued at $6,879,000 after buying an additional 53,713 shares in the last quarter. Finally, Prudential Financial Inc. boosted its stake in Simulations Plus by 16.8% in the 4th quarter. Prudential Financial Inc. now owns 210,201 shares of the technology company’s stock valued at $6,110,000 after buying an additional 30,264 shares in the last quarter. 50.12% of the stock is currently owned by institutional investors and hedge funds.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
See Also: What are gap-down stocks?
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.